# Pneumocystis jirovecii pneumonia detection and treatment

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/pneumocystis-jirovecii-pneumonia-detection-and-treatment/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the epidemiology, pathogenesis, diagnosis, and treatment of Pneumocystis pneumonia, particularly in the context of HIV infection and immunocompromised patients. It covers topics such as opportunistic infections, colonization by Pneumocystis, impact of antiretroviral therapy, and the clinical significance of Pneumocystis colonization. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t12369 |
| Works | 135 |

## Topic papers all

Showing 15 of 135.

- [Guidelines for the Management of Adults with Community-acquired Pneumonia](https://scholariq.org/papers/guidelines-for-the-management-of-adults-with-community-acquired-pneumonia/)
- [The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-results-of-direct-and-indirect-treatment-comparisons-in-meta-analysis-of/)
- [American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis](https://scholariq.org/papers/american-thoracic-society-centers-for-disease-control-and-prevention-infectious/)
- [Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015](https://scholariq.org/papers/primary-immunodeficiency-diseases-an-update-on-the-classification-from-the/)
- [Kaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.](https://scholariq.org/papers/kaposis-sarcoma-and-pneumocystis-pneumonia-among-homosexual-men-new-york-city/)
- [Pulmonary sarcoidosis](https://scholariq.org/papers/pulmonary-sarcoidosis/)
- [Towards tuberculosis elimination: an action framework for low-incidence countries](https://scholariq.org/papers/towards-tuberculosis-elimination-an-action-framework-for-low-incidence-countries/)
- [Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency](https://scholariq.org/papers/primary-immunodeficiency-diseases-an-update-on-the-classification-from-the-2/)
- [Intraocular Tuberculosis—An Update](https://scholariq.org/papers/intraocular-tuberculosis-an-update/)
- [Clinical spectrum of X-linked hyper-IgM syndrome](https://scholariq.org/papers/clinical-spectrum-of-x-linked-hyper-igm-syndrome/)
- [ERS clinical practice guidelines on treatment of sarcoidosis](https://scholariq.org/papers/ers-clinical-practice-guidelines-on-treatment-of-sarcoidosis/)
- [Management of latent<i>Mycobacterium tuberculosis</i>infection: WHO guidelines for low tuberculosis burden countries](https://scholariq.org/papers/management-of-latent-i-mycobacterium-tuberculosis-i-infection-who-guidelines-for/)
- [Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease](https://scholariq.org/papers/effect-of-patiromer-on-serum-potassium-level-in-patients-with-hyperkalemia-and/)
- [Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy](https://scholariq.org/papers/immune-restoration-disease-after-the-treatment-of-immunodeficient-hiv-infected/)
- [Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis](https://scholariq.org/papers/clinical-manifestations-of-aids-in-the-era-of-pneumocystis-prophylaxis/)

## Topic primary papers

Showing 15 of 21.

- [The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-results-of-direct-and-indirect-treatment-comparisons-in-meta-analysis-of/)
- [American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis](https://scholariq.org/papers/american-thoracic-society-centers-for-disease-control-and-prevention-infectious/)
- [Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis](https://scholariq.org/papers/clinical-manifestations-of-aids-in-the-era-of-pneumocystis-prophylaxis/)
- [Increased Susceptibility to Pulmonary Emphysema among HIV-Seropositive Smokers](https://scholariq.org/papers/increased-susceptibility-to-pulmonary-emphysema-among-hiv-seropositive-smokers/)
- [Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients](https://scholariq.org/papers/prevalence-and-etiology-of-community-acquired-pneumonia-in-immunocompromised/)
- [Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection](https://scholariq.org/papers/peripheral-blood-cd4-t-lymphocyte-counts-during-pneumocystis-carinii-pneumonia/)
- [Esophageal Disease in Human Immunodeficiency Virus Infection](https://scholariq.org/papers/esophageal-disease-in-human-immunodeficiency-virus-infection/)
- [Diagnostic Value of Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing in Pneumocystis jirovecii Pneumonia in Non-HIV Immunosuppressed Patients](https://scholariq.org/papers/diagnostic-value-of-bronchoalveolar-lavage-fluid-metagenomic-next-generation/)
- [Clinical Application of Metagenomic Next-Generation Sequencing for Suspected Infections in Patients With Primary Immunodeficiency Disease](https://scholariq.org/papers/clinical-application-of-metagenomic-next-generation-sequencing-for-suspected/)
- [IMMUNOSUPPRESSIVE DRUGS](https://scholariq.org/papers/immunosuppressive-drugs/)
- [Host Factors and Outcomes in Hospitalizations for Pneumocystis Jirovecii Pneumonia in the United States](https://scholariq.org/papers/host-factors-and-outcomes-in-hospitalizations-for-pneumocystis-jirovecii/)
- [High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center](https://scholariq.org/papers/high-incidence-and-mortality-of-pneumocystis-jirovecii-infection-in-anti-mda5/)
- [Pneumocystis jirovecii colonization in patients treated with infliximab](https://scholariq.org/papers/pneumocystis-jirovecii-colonization-in-patients-treated-with-infliximab/)
- [Effectiveness of low-dose contrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation](https://scholariq.org/papers/effectiveness-of-low-dose-contrimoxazole-prophylaxis-against-pneumocystis/)
- [Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: Risk factors and implications for infection control](https://scholariq.org/papers/pneumocystis-pneumonia-outbreak-among-renal-transplant-recipients-at-a-north/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.